(Q50990133)
Statements
Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma (English)
G Pelaia
L Gallelli
P Romeo
T Renda
M T Busceti
A Proietto
S A Marsico